US Stock MarketDetailed Quotes

Anixa Biosciences (ANIX)

Watchlist
  • 3.190
  • -0.030-0.93%
Close Jan 16 16:00 ET
  • 3.190
  • 0.0000.00%
Post 20:01 ET
106.47MMarket Cap-9.38P/E (TTM)

Anixa Biosciences (ANIX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
0
0
Gross profit
0
0
0
0
Operating expense
-15.40%11.7M
-9.07%2.88M
-32.18%2.44M
-13.38%3M
-6.18%3.39M
25.05%13.83M
3.67%3.16M
26.30%3.59M
32.89%3.47M
41.20%3.61M
Selling and administrative expenses
-10.83%6.63M
2.79%1.73M
-17.16%1.38M
-7.69%1.68M
-18.85%1.83M
18.18%7.44M
17.48%1.69M
-5.07%1.67M
13.04%1.82M
51.88%2.26M
-General and administrative expense
-10.83%6.63M
2.79%1.73M
-17.16%1.38M
-7.69%1.68M
-18.85%1.83M
18.18%7.44M
17.48%1.69M
-5.07%1.67M
13.04%1.82M
51.88%2.26M
Research and development costs
-20.72%5.07M
-22.63%1.14M
-45.19%1.06M
-19.68%1.32M
15.05%1.55M
34.12%6.4M
-8.61%1.48M
76.93%1.93M
64.93%1.65M
26.31%1.35M
Operating profit
15.40%-11.7M
9.07%-2.88M
32.18%-2.44M
13.38%-3M
6.18%-3.39M
-25.61%-13.83M
-3.67%-3.16M
-26.30%-3.59M
-35.43%-3.47M
-41.20%-3.61M
Net non-operating interest income expense
-40.60%673K
-38.40%154K
-43.68%156K
-33.80%190K
-45.77%173K
4.81%1.13M
-24.24%250K
-6.42%277K
13.44%287K
57.92%319K
Non-operating interest income
-40.60%673K
-38.40%154K
-43.68%156K
-33.80%190K
-45.77%173K
4.81%1.13M
-24.24%250K
-6.42%277K
13.44%287K
57.92%319K
Other net income (expense)
Income before tax
13.15%-11.03M
6.56%-2.72M
31.22%-2.28M
11.54%-2.81M
2.34%-3.21M
-27.88%-12.7M
-7.06%-2.91M
-30.10%-3.32M
-37.84%-3.18M
-39.76%-3.29M
Income tax
Net income
13.15%-11.03M
6.56%-2.72M
31.22%-2.28M
11.54%-2.81M
2.34%-3.21M
-27.88%-12.7M
-7.06%-2.91M
-30.10%-3.32M
-37.84%-3.18M
-39.76%-3.29M
Net income continuous Operations
13.15%-11.03M
6.56%-2.72M
31.22%-2.28M
11.54%-2.81M
2.34%-3.21M
-27.88%-12.7M
-7.06%-2.91M
-30.10%-3.32M
-37.84%-3.18M
-39.76%-3.29M
Minority interest income
29.86%-101K
10.00%-27K
42.11%-22K
43.90%-23K
17.14%-29K
-21.01%-144K
3.23%-30K
-2.70%-38K
-115.79%-41K
-9.38%-35K
Net income attributable to the parent company
12.96%-10.93M
6.52%-2.7M
31.10%-2.26M
11.12%-2.79M
2.18%-3.18M
-27.96%-12.55M
-7.17%-2.88M
-30.51%-3.28M
-37.19%-3.14M
-40.18%-3.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.96%-10.93M
6.52%-2.7M
31.10%-2.26M
11.12%-2.79M
2.18%-3.18M
-27.96%-12.55M
-7.17%-2.88M
-30.51%-3.28M
-37.19%-3.14M
-40.18%-3.26M
Basic earnings per share
12.82%-0.34
0.00%-0.09
30.00%-0.07
10.00%-0.09
0.00%-0.1
-21.88%-0.39
0.00%-0.09
-25.00%-0.1
-42.86%-0.1
-25.00%-0.1
Diluted earnings per share
12.82%-0.34
0.00%-0.09
30.00%-0.07
10.00%-0.09
0.00%-0.1
-21.88%-0.39
0.00%-0.09
-25.00%-0.1
-42.86%-0.1
-25.00%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0000
Gross profit 0000
Operating expense -15.40%11.7M-9.07%2.88M-32.18%2.44M-13.38%3M-6.18%3.39M25.05%13.83M3.67%3.16M26.30%3.59M32.89%3.47M41.20%3.61M
Selling and administrative expenses -10.83%6.63M2.79%1.73M-17.16%1.38M-7.69%1.68M-18.85%1.83M18.18%7.44M17.48%1.69M-5.07%1.67M13.04%1.82M51.88%2.26M
-General and administrative expense -10.83%6.63M2.79%1.73M-17.16%1.38M-7.69%1.68M-18.85%1.83M18.18%7.44M17.48%1.69M-5.07%1.67M13.04%1.82M51.88%2.26M
Research and development costs -20.72%5.07M-22.63%1.14M-45.19%1.06M-19.68%1.32M15.05%1.55M34.12%6.4M-8.61%1.48M76.93%1.93M64.93%1.65M26.31%1.35M
Operating profit 15.40%-11.7M9.07%-2.88M32.18%-2.44M13.38%-3M6.18%-3.39M-25.61%-13.83M-3.67%-3.16M-26.30%-3.59M-35.43%-3.47M-41.20%-3.61M
Net non-operating interest income expense -40.60%673K-38.40%154K-43.68%156K-33.80%190K-45.77%173K4.81%1.13M-24.24%250K-6.42%277K13.44%287K57.92%319K
Non-operating interest income -40.60%673K-38.40%154K-43.68%156K-33.80%190K-45.77%173K4.81%1.13M-24.24%250K-6.42%277K13.44%287K57.92%319K
Other net income (expense)
Income before tax 13.15%-11.03M6.56%-2.72M31.22%-2.28M11.54%-2.81M2.34%-3.21M-27.88%-12.7M-7.06%-2.91M-30.10%-3.32M-37.84%-3.18M-39.76%-3.29M
Income tax
Net income 13.15%-11.03M6.56%-2.72M31.22%-2.28M11.54%-2.81M2.34%-3.21M-27.88%-12.7M-7.06%-2.91M-30.10%-3.32M-37.84%-3.18M-39.76%-3.29M
Net income continuous Operations 13.15%-11.03M6.56%-2.72M31.22%-2.28M11.54%-2.81M2.34%-3.21M-27.88%-12.7M-7.06%-2.91M-30.10%-3.32M-37.84%-3.18M-39.76%-3.29M
Minority interest income 29.86%-101K10.00%-27K42.11%-22K43.90%-23K17.14%-29K-21.01%-144K3.23%-30K-2.70%-38K-115.79%-41K-9.38%-35K
Net income attributable to the parent company 12.96%-10.93M6.52%-2.7M31.10%-2.26M11.12%-2.79M2.18%-3.18M-27.96%-12.55M-7.17%-2.88M-30.51%-3.28M-37.19%-3.14M-40.18%-3.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 12.96%-10.93M6.52%-2.7M31.10%-2.26M11.12%-2.79M2.18%-3.18M-27.96%-12.55M-7.17%-2.88M-30.51%-3.28M-37.19%-3.14M-40.18%-3.26M
Basic earnings per share 12.82%-0.340.00%-0.0930.00%-0.0710.00%-0.090.00%-0.1-21.88%-0.390.00%-0.09-25.00%-0.1-42.86%-0.1-25.00%-0.1
Diluted earnings per share 12.82%-0.340.00%-0.0930.00%-0.0710.00%-0.090.00%-0.1-21.88%-0.390.00%-0.09-25.00%-0.1-42.86%-0.1-25.00%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------Unqualified Opinion--------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More